跳至主要内容
临床试验/NCT03981185
NCT03981185撤回不适用

Accelerated Theta Burst Stimulation for Treatment of Depression in Individuals With Detoxed Alcohol Use Disorder

Stanford University0 个研究点开始时间: 2024年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
主要终点
Change from baseline Montgomery Asberg Depression Rating Scale (MADRS)

研究概览

简要总结

This study evaluates an accelerated schedule of theta-burst stimulation using a transcranial magnetic stimulation device for improvement of depressive symptoms and drinking behavior in individuals with alcohol dependence. In this open label study, all participants will receive accelerated theta-burst stimulation.

详细描述

Repetitive transcranial magnetic stimulation (rTMS) is a noninvasive procedure and an established technology. Research utilizing rTMS in patients with alcohol use disorder has shown some promising results. The limitations of this approach include the duration of the treatment (approximately 40 minutes per treatment session). Recently, researchers have aggressively pursued modifying the treatment parameters, such as using accelerated intermittent theta-burst stimulation (aiTBS), to reduce treatment times with possible enhanced efficacy with some preliminary success. This study intends to further modify the parameters to create a more rapid form of the treatment and look at the change in neuroimaging biomarkers.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Change from baseline Montgomery Asberg Depression Rating Scale (MADRS)

时间窗: Baseline and 1 month post-stimulation

A ten item diagnostic questionnaire used to measure the severity of depressive episodes in patients with mood disorders. The MADRS uses a 0 to 6 severity scale, scored following the interview. Scoring/Interpretation: Higher scores indicate increasing depressive symptoms. ... Cut-off points include: 0 to 6 - symptom absent, 7 to 19 - mild depression, 30 to 34 - moderate, 35 to 60 - severe depression.

次要结局

  • Change in alcohol craving and consumption measured by Obsessive Compulsive Drinking Scale (OCDS)(Baseline and 1 month post-stimulation)
  • Change in heart rate variability(At the beginning and end of each stimulation day)
  • Change in functional connectivity from baseline as measured by MR imaging(Baseline and 1 month post-stimulation)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Gregory Sahlem

Assistant Professor

Stanford University

相似试验

aTBS for Treatment of Depression in AUD | 临床试验